Johnson & Johnson announced a $5.5 billion settlement to resolve litigation linking its talc products to ovarian cancer, marking the conclusion of a decade-long legal dispute involving tens of thousands of plaintiffs.
The agreement covers approximately 76,000 claims, including consolidated federal cases in New Jersey and related state court matters, effectively addressing nearly all remaining talc-related lawsuits against the company.
Plaintiffs’ legal representatives confirmed the settlement as a favorable outcome after a 10-year courtroom battle, with the agreement requiring approval from 95% of claimants before finalization.
Erik Haas, Johnson & Johnson’s litigation vice-president, stated the company viewed the claims as “meritless” and opted to settle for closure, though acknowledging the company could have prevailed through further litigation.
The settlement structure includes $3 billion in payments by 2027, with additional funds in 2028. However, the total payout may exceed this amount based on participant uptake, according to lawyer Chris Seeger, who represented 2,500 plaintiffs.
The agreement assigns specific compensation values to qualifying ovarian cancer claims without capping Johnson & Johnson’s total liability. Seeger described the settlement as “fair,” emphasizing client satisfaction.
The company secured the deal through a combination of court victories, including individual trial wins, successful challenges to plaintiffs’ lawyers, and rulings against plaintiff-expert testimonies.
A recent federal court rejection of plaintiffs’ ability to prove talc’s direct role in their cancer further strengthened Johnson & Johnson’s position, despite its long-standing denial of talc safety issues.
Headquartered in New Jersey, the company discontinued talc-based baby powder in 2020 in favor of cornstarch but faced renewed litigation in March 2025 after a failed bankruptcy strategy involving shell-company subsidiaries.
Notably, the settlement excludes future claims, concentrating resources on current plaintiffs compared to earlier bankruptcy proposals. Payments will be settled within 18 months rather than extended over a decade, as noted by Seeger.
